Oncology Drug Snapshot: Axitinib (Inlyta)

April 9, 2015
Cancer Network Editors
Cancer Network Editors

This oncology drug snapshot takes a look at axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.